scispace - formally typeset
H

Himani Chaurasia

Researcher at Allahabad University

Publications -  10
Citations -  84

Himani Chaurasia is an academic researcher from Allahabad University. The author has contributed to research in topics: Chemistry & Antimicrobial. The author has an hindex of 3, co-authored 7 publications receiving 29 citations.

Papers
More filters
Journal ArticleDOI

Anti-HIV potential of diarylpyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors: design, synthesis, docking, TOPKAT analysis and molecular dynamics simulations.

TL;DR: The designed diarylpyrimidine derivatives have shown promising docking results, which revealed that all compounds formed hydrogen bonds with Lys101, Lys103, Tyr 181, Tyr318 and π- interactions with Tyr181, Tyr188, Phe227 and Trp229 amino acid residues located in the non-nucleoside inhibitor binding pocket of HIV-RT protein.
Journal ArticleDOI

Molecular modeling, QSAR analysis and antimicrobial properties of Schiff base derivatives of isatin

TL;DR: The study laid the foundation for the development of better antibacterial agents via a combination approach and safe agricultural fungicides through in vitro antimicrobial activity of a new series of novel Schiff bases.
Journal ArticleDOI

Docking, ADMET prediction, DFT analysis, synthesis, cytotoxicity, antibacterial screening and QSAR analysis of diarylpyrimidine derivatives

TL;DR: In vitro evaluation of cytotoxicity indicates that these molecules were less toxic against HEK293 (Human embryonic kidney) cell lines, and molecular docking assessment revealed that all designed 2,4 disubstituted diarylpyrimidine derivatives showed good interaction within active site of PDF enzyme.
Book ChapterDOI

Wastewater Treatment Through Nanotechnology: Role and Prospects

TL;DR: In this article, the characteristics of different nanomaterials and their role in the restoration of aquatic ecosystem are comprehensively described. But, the focus of this paper is not on the application of nanotechnology in water treatment.
Journal ArticleDOI

Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.

TL;DR: Sarma et al. as mentioned in this paper designed and synthesized quinoline derivatives as probable protease inhibitors (PIs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2-Mpro).